2016, Number 5
<< Back Next >>
AMC 2016; 20 (5)
Congenital hydranencephaly: report of an adolescent in the north of Mexico
Barrón-Muñoz MÁ, Hernández-Reyes C, Serna-Valdés RE, Torres-Flores J
Language: Spanish
References: 12
Page: 546-552
PDF size: 579.47 Kb.
ABSTRACT
Background: hydranencephaly is the total or almost total absence o f the cerebral hemispheres
with persistent cerebrospinal fluid, which affects individuals around the world regardless of gender or
ethnicity. There is no effective and curative treatment, and most patients die before reaching the third
year of life, although some exceptions can come of age, always requiring multidisciplinary support.
Objective: to present the case o f an adolescent male w ith congenital hydranencephaly.
Clinical case: a 11-year-old male from 11 who was admitted at the age of 5 referred to as holoprosencephaly.
He was born by caesarean section at 38 weeks of gestation due to rupture of membranes with
normal somatometry and Apgar 5, requiring advanced neonatal resuscitation maneuvers. At 30 days
head circumference increased to 39 cm and was increasing, reaching 54 cm at 6 months of age. The patient
has no control head and trunk, and he was not capable of bipedalism, or developed language or
sound emission. A brain scan performed on admission revealed brain parenchyma islets and meninges,
corresponding to hydranencephaly. The case is presented by the infrequency with which patients reach
adolescence.
Conclusions: hydranencephaly is a disease that is usually fatal, and cases that survive have
severe and disabling neurological sequeles. Although some genetic syndromes associated with hydranencephaly
are known, most cases are usually sporadic with no other manifestations. Though the hope that
the case presented shows greater progress in their neurological development is not encouraging, physical,
occupational and pulmonary therapy may allow better quality of life.
REFERENCES
Cecchetto G, Milanese L, Giordano R, Viero A, Suma V, Manara R. Looking at the missing brain: hydranencephaly case series and literature review. Pediatr Neurol. 2013 Feb;48(2):152-8.
Gardea-Loera G, Velazco-Campos M. Aspec-tos clínicos de neuroimagen y comporta-miento electrofisiológico de la hidranence-falia. Arch Neurocien (Mex). 2014;19(1):48-52.
Pavone P, Praticó AD, Vitaliti G, Ruggieri M, Rizzo R, Parano E, et al. Hydranencephaly: cerebral spinal fluid instead of cerebral mantles. Ital J Pediatr. 2014 Oct 18;40:79.
Ray C, Mobley J, Thompson M, Nagy L. Hy-dranencephaly: Considering prolonged survival and treatment by endoscopic cho-roid plexus coagulation. Turk Neurosurg. 2015;25(5):788-92.
Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-2.
Gómez Soriano J, Cano de la Cuerda R, Mu-ñoz Hellín E, Ortíz Gutiérrez R, Taylor JS. Valoración y cuantificación de la espastici-dad: revisión de los métodos clínicos, bio-mecánicos y neurofisiológicos. Rev Neurol. 2012;55(4):217-26.
Tardieu G, Shentoub S, Delarue R. Research on a technic for measurement of spastici-ty. Rev Neurol (Paris). 1954;91:143-4.
Crowe JF, Mani VJ, Ranawat CS. Total hip re-placement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg. 1979;61A:15-23.
Palisano R, Rosembaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross mo-tor function in children with cerebral palsy. Dev Med Child Neurol. 1997 Apr;39(4):214-23.
Pachajoa H, Ariza Y, Isaza C, Méndez F. De-fectos por disrupción vascular no asocia-dos con alteraciones cromosómicas. Gine-col Obstet Mex. 2015;83:657-61.
Sarno M, Sacramento GA, Khouri R, Rosário MS do, Costa F, Archanjo G, et al. Zika vi-rus Infection and stillbirths: a case of hy-drops fetales, hydranencephaly and fetal demise. PLoS Negl Trop Dis. 2016;10(2):e0004517.
Lacunza Paredes RO, Correa López W. Hi-dranencefalia como presentación más se-vera de apoplejía cerebral fetal: a propósi-to de dos casos. Rev Peruana Ginecol Obs-tet. 2014;2:183-7.